CEO INTERVIEW: From Abraxane to What's Next: Dr. Vuong Trieu on Building Multi-Billion Dollar Biotech Value
The Harvest Podcast by Carmel Fisher
Episode notes
Essential listening for biotech investors: Host Carmel Fisher interviews Dr. Vuong Trieu, Chairman and CEO of Oncotelic Therapeutics Inc. (OTCQB: OTLC), who has a proven track record of generating multi-billion dollar returns in biotech.
Investment Thesis: Dr. Trieu previously delivered $2.9 billion (Abraxane®/Celgene) and ...
Keywords
biosciencesotcmarketscarmel fisherOTCQBthe harvest podcastthe harvestbiotechbiopharmapharmaceuticalsharvest communicationscapital marketsbiotherapeuticsceo interviewsinvestment portfolioBiotechInvestingabraxanepatentscynviloqDr. Trieu$OTLCOncotelic Therapeuticsregulatory announcementsmilestoneslate-stage assetsportfolio diversification